Article
Allen & Overy's Nicole Daley on the rebound in M&A activity in the pharma industry
Nicole Daley, life sciences and M&A partner at Allen & Overy, discussed the steady pickup in M&A in the pharma industry after years of underperformance with PharmaVoice.
Nicole shared her thoughts on portfolio diversification and additive dealmaking, and how companies with a sharper focus can be more appealing to investors in the life sciences arena.
Read the full PharmaVoice article here.
Disclaimer:
First published on PharmaVoice.com on the 19th March.
Content Disclaimer
This content was originally published by Allen & Overy before the A&O Shearman merger
Related capabilities